Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Sale | 2024-11-20 4:10 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 197 | $2.165 | $427 | 162,355 (Direct) | View |
| 2024-10-17 Sale | 2024-10-18 4:08 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 107 | $2.119 | $227 | 162,552 (Direct) | View |
| 2024-09-17 Sale | 2024-09-18 4:11 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,608 | $1.783 | $4,650 | 162,659 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 4:03 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 211 | $1.946 | $411 | 165,267 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:30 am | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 108 | $2.587 | $279 | 165,478 (Direct) | View |
| 2024-06-18 Sale | 2024-06-20 4:16 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,540 | $2.856 | $7,254 | 165,586 (Direct) | View |
| 2024-05-17 Sale | 2024-05-20 4:14 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 192 | $2.483 | $477 | 168,126 (Direct) | View |
| 2023-09-20 Sale | 2023-09-21 5:06 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 742 | $1.245 | $924 | 68,318 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 4:32 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 243 | $1.414 | $344 | 69,060 (Direct) | View |
| 2023-07-19 Sale | 2023-07-20 4:38 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 106 | $1.585 | $168 | 69,303 (Direct) | View |
| 2023-06-21 Sale | 2023-06-22 4:45 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 603 | $1.483 | $894 | 69,409 (Direct) | View |
| 2023-05-17 Sale | 2023-05-18 4:07 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 219 | $1.624 | $356 | 70,012 (Direct) | View |
| 2023-04-19 Sale | 2023-04-20 4:12 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 115 | $1.278 | $147 | 70,231 (Direct) | View |
| 2023-03-17 Sale | 2023-03-20 4:16 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 526 | $1.7823 | $937 | 70,346 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:22 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 5,090 | $5.055 | $25,730 | 48,572 (Direct) | View |
| 2022-10-18 Sale | 2022-10-19 4:11 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 107 | $7.69 | $823 | 53,662 (Direct) | View |
| 2022-09-19 Sale | 2022-09-20 4:09 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 255 | $6.921 | $1,765 | 53,769 (Direct) | View |
| 2022-08-31 Purchase | 2022-08-31 4:14 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 1,000 | $7.46 | $7,460 | 54,024 (Direct) | View |
| 2022-08-17 Sale | 2022-08-18 4:10 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 199 | $6.815 | $1,356 | 53,024 (Direct) | View |
| 2022-07-19 Sale | 2022-07-20 4:27 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 431 | $6.582 | $2,837 | 53,223 (Direct) | View |
| 2022-06-17 Sale | 2022-06-21 4:06 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 256 | $4.9 | $1,254 | 53,654 (Direct) | View |
| 2022-05-17 Sale | 2022-05-18 4:30 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 196 | $5.981 | $1,172 | 53,910 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Option Award | 2024-03-15 4:35 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 250,000 | $0 | 318,318 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:22 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 116,800 | $0 | 165,372 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:46 pm | N/A 2032-06-07 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 52,000 | $0 | 52,000 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-16 5:11 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 13,000 | $0 | 111,106 (Direct) | View |
Ownership | 2022-03-09 4:53 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 0 | $0 | 41,106 (Direct) | View |